UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): ~~December~~February 219, ~~2017~~2018

PixarBio Corporation

(Name of Small Business Issuer in its Charter)

Delaware

47-1945113

(State or Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer Identification No.)

8B Industrial Way Salem, NH 03079

(Address of principal executive offices)

(617) 803-8838

(Telephone Number of Principal Executive Offices)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 2479.374a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 2479.374d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 2479.373e-4c))

Item 5.02 Departure of Directors or Certain Officers~~; Election of Certain Directors; Appointment of Certain Officers~~

OnPursuant ~~December~~to 21a Written Consent by the Board of Directors of PixarBio Corporation (the “Company”) dated February 5, ~~2017~~2018, on February 9, 2018 Katrin Holzhaus was ~~removed~~notified ~~from~~of her removal for cause as the Chief Administration Officer and Corporate Secretary of the Company. Francis M. Reynolds, the Company’s co-founder, Chief Executive Officer, President, Chief Financial Officer, Chief Scientific Officer and Chairman of the Board of Directors ofwas appointed as the Company’s Corporate Secretary.

~~On December 21, 2017, Laura Morse was removed from the Board of Directors of the Company.~~ SIGNATURES

OnPursuant ~~December~~to ~~22,~~the ~~2017,~~requirements ~~Bernard Ho was appointed as a member~~ of the ~~Board~~Securities ofExchange ~~Directors~~Act of 1934, the ~~Company.~~registrant Hehas ~~shall~~duly ~~serve~~caused onthis ~~the~~report ~~Audit~~to ~~Committee~~be ~~and~~signed on ~~the~~its ~~General~~behalf ~~Nominating~~by ~~and Compensation Committee of~~ the ~~Board~~undersigned ofhereunto ~~Directors~~duly ~~of the Company~~authorized.

SIGNATURES

PixarBio Corporation (the Company)
Dated February 15, 2018	By:	/s/ Francis M. Reynolds
Name: Francis M. Reynolds
Title: Chief Executive Officer

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~2

PixarBio Corporation (the Company)
Dated: December 28, 2017	By:	/s/ Francis M. Reynolds
Name: Francis M. Reynolds
Title: Chief Executive Officer

Filing Compare · PixarBio Corp